Financials

News Ideas Technicals

1061 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ESSEX BIO-TECHNOLOGY operating, investing, and financing activities

1061 free cash flow for H2 23 is 166.13 M HKD. For 2023, 1061 free cash flow was 312.86 M HKD and operating cash flow was 333.89 M HKD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—